跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Piroxisaph-20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Piroxisaph-20
Approved
STANDARD
Piroxisaph-20
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c986c43925319940
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c986c43925319940
Drug Approval Philippines Name
Piroxisaph-20
Product Name
Piroxisaph-20
Registration Number
DRP-11787
Brand Name
Piroxisaph-20
Generic Name
Piroxicam
Dosage Form
Capsule
Dosage Strength
20 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Ollen Pharma Trading, Inc.
Distributor
Ollen Pharma Trading, Inc.
Issuance Date
29 April 2022
Expiry Date
29 April 2027
Pharmacologic Category
Non-Steroidal Anti-inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c986c43925319940
Type
Standard
Back to Philippines FDA Approvals